Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varlitinib in Advanced/Metastatic HCC
NCT03499626Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- May 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varlitinib in hepatocellular carcinoma (HCC), sponsored by National University Hospital. Status: unknown.
02
Drugs
varlitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03499626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499626.